News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
<Results> Haohai Biological Technology (06826.HK) 1Q Net Profit RMB73.56 million, Down 18.6% YoY
Haohai Biological Technology (06826.HK) announced its first quarter results. Under China Accounting Standards, revenue amounted to RMB571 million, down 7.6% YoY. Net profit attribu...
Reset
Send
The window will close in 5 seconds
<Results> Haohai Biological Technology (06826.HK) 1Q Net Profit RMB73.56 million, Down 18.6% YoY
Close
Recommend
1
Positive
1
Negative
0
 
SHORT SELL
 
STOCK INFO
aacat by AASTOCKS
Open a new trading account to get NVDA share!

Haohai Biological Technology (06826.HK)  -0.020 (-0.090%)   announced its first quarter results. Under China Accounting Standards, revenue amounted to RMB571 million, down 7.6% YoY. Net profit attributable to shareholders was RMB73.56 million, representing a decline of 18.6% YoY. EPS was RMB0.32. (de/d)(HK stocks quote is delayed for at least 15 mins.)

Dividend History
Announce DateEventParticular
2026/03/20FinalD:RMB 0.6000
2025/10/243rd QuarterlyNo Dividend
2025/08/22InterimD:RMB 0.4000 (Equivalent to approximately HKD 0.438462)
2025/04/251st QuarterlyNo Dividend



This article was automatically translated by AI, the Chinese version should be considered the authoritative version. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation.

Auto-translated by AI
View Original Text

AASTOCKS Financial News
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.